Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Klein

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
The Lancet. Global Health|September 16, 2022
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling studyAmy K Winter, Brian Lambert, Daniel Klein, et al.
Nature Communications|April 10, 2025
Antibacterial macrocyclic peptides reveal a distinct mode of BamA inhibitionMorgan E Walker, Wei Zhu, Janine H Peterson, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2017
Discovery and optimization of 2-pyridinone aminal integrase strand transfer inhibitors for the treatment of HIVJohn D Schreier, Mark W Embrey, Izzat T Raheem, et al.
Journal of Medicinal Chemistry|December 29, 2015
Correction to Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer InhibitorsIzzat T Raheem, Abbas M Walji, Daniel Klein, et al.
Journal of Medicinal Chemistry|September 24, 2015
Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer InhibitorsIzzat T Raheem, Abbas M Walji, Daniel Klein, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
The Lancet. Global Health|September 16, 2022
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling studyAmy K Winter, Brian Lambert, Daniel Klein, et al.
Nature Communications|April 10, 2025
Antibacterial macrocyclic peptides reveal a distinct mode of BamA inhibitionMorgan E Walker, Wei Zhu, Janine H Peterson, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2017
Discovery and optimization of 2-pyridinone aminal integrase strand transfer inhibitors for the treatment of HIVJohn D Schreier, Mark W Embrey, Izzat T Raheem, et al.
Journal of Medicinal Chemistry|December 29, 2015
Correction to Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer InhibitorsIzzat T Raheem, Abbas M Walji, Daniel Klein, et al.
Journal of Medicinal Chemistry|September 24, 2015
Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer InhibitorsIzzat T Raheem, Abbas M Walji, Daniel Klein, et al.
Pageof 12